Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −253,153−100.0% | Sold out | Holders |
| Q1 2026 | 253,153 | $4.59M | <0.1% | −159,287−38.6% | Reduced | Holders |
| Q4 2025 | 412,440 | $8.07M | <0.1% | −417,329−50.3% | Reduced | Holders |
| Q3 2025 | 829,769 | $10.5M | <0.1% | +37,782+4.8% | Added | Holders |
| Q2 2025 | 791,987 | $7.54M | <0.1% | +111,151+16.3% | Added | Holders |
| Q1 2025 | 680,836 | $7.12M | <0.1% | +413,459+154.6% | Added | Holders |
| Q4 2024 | 267,377 | $6.30M | <0.1% | +244,211+1,054.2% | Added | Holders |
| Q3 2024 | 23,166 | $832.1K | <0.1% | +23,166 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −100,656−100.0% | Sold out | Holders |
| Q1 2024 | 100,656 | $2.86M | <0.1% | +47,312+88.7% | Added | Holders |
| Q4 2023 | 53,344 | $709.5K | <0.1% | +53,344 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −17,726−100.0% | Sold out | Holders |
| Q1 2023 | 17,726 | $204.2K | <0.1% | +17,726 | New | Holders |